VYNT Stock, Vyant Bio Inc. Information

Vyant Bio Inc. Vyant Bio is emerging as an advanced biotechnology drug discovery company. With capabilities in data science both biology and chemistry engineering and regulatory we are rapidly identifying small and large molecule therapeutics and derisking decision making through multiple in silico in vitro and in vivo modalities. Leveraging these modalities Vyant Bio is able to capitalize on repurposed and novel compounds and then partner with others to further develop and commercialize valuable therapeutics and new treatments for patients. Vyant Bio operates two wholly-owned subsidiaries StemoniX and vivoPharm. Formerly known as Cancer Genetics Inc. the company name was changed to Vyant Bio Inc. in March 2021. Vyant Bio is headquartered in the US with offices in Europe and Australia.